Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Roivant Sciences Ltd’s current trading price is -11.72% away from its 52-week high, while its distance from the 52-week low is 32.02%. The stock’s price range during this period has varied between $8.73 and $13.06. The company, active in the Healthcare sector, saw a trading volume of around 1.51 million for the day, considerably lower average daily volume of 6.16 million observed over the last three months.
Roivant Sciences Ltd (ROIV) currently has a stock price of $11.52. The stock saw a sharp increase in the last trading session, hitting a high of $22.0 after opening at $11.52. The lowest recorded price for the day was $12.0 before it closed at $11.39.
The market performance of Roivant Sciences Ltd has been somewhat unstable. Over the past year, the company’s stock achieved a high of $13.06 on 09/09/24, with the lowest value for the same timeframe being $8.73, recorded on 04/07/25.
How Financial Performance Impacts Market Capitalization
Roivant Sciences Ltd (ROIV) has experienced a quarterly rise of 7.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.83B and boasts a workforce of 750 employees.
Decoding Analysts’ Ratings for Roivant Sciences Ltd
As of right now, 6 analysts are rating Roivant Sciences Ltd as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.87, with a change in price of +0.76. Similarly, Roivant Sciences Ltd recorded 6,586,271 in trading volume during the last 100 days, posting a change of +7.03%.
How ROIV’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ROIV stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
ROIV Stock Stochastic Average
As of today, the raw stochastic average of Roivant Sciences Ltd over the last 50 days is at 74.09%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 73.49%. Further, the company’s Stochastic %K and %D values for the last 20 days were 69.61% and 69.07%, respectively.
ROIV Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a gain of 3.55%.However, over the last six months, we can see a weaker performance of 3.27%. Over the last 30 days, the price of ROIV has leaped by -0.13%. And in the last five days, it has fallen by -1.07%.
